Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Alnylam Pharmaceuticals (ALNY US)
Watchlist
88
Analysis
Health Care
•
United States
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Seagate
•
11 Dec 2025 09:12
Nasdaq100 December 2025 Forecast (Final): 12 Changes
​STX, ALNY, WDC are the top forecasted addition. TTD, ON, LULU are the top forecasted deletions. FER can be a surprise addition displacing EBAY.
Dimitris Ioannidis
3.6k Views
Share
bullish
•
Marvell Technology
•
04 Dec 2025 06:22
Marvell Technology (MRVL US): Heroic Earnings Unlock S&P500 Eligibility
MRVL is labelled bullish for index rebalance but bearish in fundamentals following the fourth consecutive positive earnings and high price-to...
Dimitris Ioannidis
2k Views
Share
bullish
•
CRH
•
03 Dec 2025 19:11
Quiddity Leaderboard SP500/600 Dec25 Rebal: Last Minute Surprise in The Leading Names
SP500 rankings will be decided at today's open and announced on 5 December after the close. We see $100bn to trade across the SP500 complex. Kalshi...
Anjana Amarasuriya
Follow
587 Views
Share
bullish
•
Comfort Systems Usa
•
03 Dec 2025 10:12
S&P500 December 2025 Final Forecast: FIX & CRH Leading the Pack
​CRH and FIX are top candidates for addition in December 2025, while PSTG and SOLS face reduced conviction. VRT has a higher chance of inclusion...
Dimitris Ioannidis
1.6k Views
Share
bullish
•
CRH
•
22 Nov 2025 22:08
[Quiddity Index] SP500/600 Dec25 Rebal: Two ADDs Two DELs and 3 Intra-Review Changes Likely Soon
SP500 could see two changes in Dec25. One has a lot to buy if chosen. There are also a few intra-review actions/changes scheduled for the near...
Travis Lundy
Follow
638 Views
Share
First
Previous
9
10
11
12
13
14
15
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x